Verdant Nature LLC (Chicago), a vertically integrated producer of phytocannabinoid and cannabidiol-rich (CBD) hemp oil products, has partnered with CReDO Science LLC, a biopharma company commercializing patented products from the cannabis plant. The companies will work together to develop proprietary hemp-derived formulations for clients.
Verdant Nature manufactures the Verdant Oasis ingredient brand. Its products are available in USDA NOP–organic and conventional formats (oil, powder, and water-dispersible forms).
CReDO Science is led by Ethan Russo, MD, a board-certified neurologist and psychopharmacology researcher and formulator in the medical cannabis field. He is the author of more than 50 peer-reviewed journal articles and seven books on cannabis and the endocannabinoid system, and served as a medical monitor and study physician on 23 clinical trials for cannabis-based pharmaceuticals.
“Having Dr. Russo work with Verdant Nature R&D catapults our ability to support our clients in crafting distinctive endocannabinoid system–support products,” stated Carl Germano, CNS, CDN, vice president of Verdant Nature, in a press release. “Dr. Russo’s impeccable credentials and expertise in cannabinoid medicine will provide the guidance needed to help our clients stand out among the single magic-bullet CBD products pervading the marketplace.”